With respect to the investments made in the facility in Quebec for Medicago, as with all projects that are ultimately supported through our colleagues at the strategic innovation fund within the Department of Industry—or ISED—rigorous due diligence is performed, as well as expert advice in the context of vaccine and biomanufacturing projects through the vaccine task force, which provides advice on all projects moving forward. There was a process followed and a decision made to fund in accordance with the policies and procedures that are followed for all investments made.
On March 21st, 2022. See this statement in context.